GCM
CRMD icon

Ghisallo Capital Management’s CorMedix CRMD Stock Holding History

Ghisallo Capital Management’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-750,000
Closed -$9.24M – 226
2025
Q2 		$9.24M Buy
+750,000
New +$8.28M 0.25% 82
2023
Q3 		– Sell
-250,000
Closed -$991K – 128
2023
Q2 		$991K Buy
+250,000
New +$1.24M 0.12% 95

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ghisallo Capital Management's CRMD Position: Q3 2025 in Review

Ghisallo Capital Management sold out of CorMedix (CRMD) in Q3 2025, closing a stake of 750,000 shares — an estimated $9.24M sold.

Ghisallo Capital Management first reported a position in CRMD in Q2 2023 and held it in 2 quarters. The position peaked at $9.24M in Q2 2025. 190 funds tracked by Wall St. Rank hold CRMD as of Q3 2025.

  • Ghisallo Capital Management reported no remaining CorMedix position as of Q3 2025 after selling out during the quarter.
  • Ghisallo Capital Management sold 750,000 CorMedix shares in Q3 2025, an estimated $9.24M.
  • Ghisallo Capital Management first reported a position in CorMedix in Q2 2023 and held it in 2 quarters.
  • Ghisallo Capital Management's CorMedix position peaked at $9.24M in Q2 2025.
  • 190 funds tracked by Wall St. Rank held CorMedix as of Q3 2025.

Based on Ghisallo Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.